Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaping He

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Breast Cancer Research : BCR|April 22, 2006
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assayLaurent Perreard, Cheng Fan, John F Quackenbush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.
Cell Reports|October 18, 2018
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastYeji An, Jessica R Adams, Daniel P Hollern, et al.
Cancer Research|May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsBryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.
The Journal of Clinical Investigation|June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseSusana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast CancerErika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, et al.
Cancer Discovery|January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexJon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|April 22, 2006
Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assayLaurent Perreard, Cheng Fan, John F Quackenbush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Supervised risk predictor of breast cancer based on intrinsic subtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2023
Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S Parker, Michael Mullins, Maggie C U Cheang, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.
Cell Reports|October 18, 2018
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastYeji An, Jessica R Adams, Daniel P Hollern, et al.
Cancer Research|May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsBryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.
The Journal of Clinical Investigation|June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseSusana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast CancerErika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, et al.
Cancer Discovery|January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexJon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
Pageof 6